[HTML][HTML] Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)

YH Chu, D Dias-Santagata, AA Farahani, B Boyraz… - Modern Pathology, 2020 - Elsevier
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical
behavior, histologic characteristics, and molecular landscape are not well understood. We …

[HTML][HTML] Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)

YH Chu, D Dias-Santagata, AA Farahani… - Modern pathology: an …, 2020 - ncbi.nlm.nih.gov
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical
behavior, histologic characteristics, and molecular landscape are not well understood. We …

Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)

YH Chu, D Dias-Santagata… - … : an official journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical
behavior, histologic characteristics, and molecular landscape are not well understood. We …

Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)

YH Chu, D Dias-Santagata, AA Farahani, B Boyraz… - Modern …, 2020 - nature.com
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical
behavior, histologic characteristics, and molecular landscape are not well understood. We …

[HTML][HTML] Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)

YH Chu, D Dias-Santagata, AA Farahani… - Modern …, 2020 - modernpathology.org
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical
behavior, histologic characteristics, and molecular landscape are not well understood. We …

Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).

YH Chu, D Dias-Santagata, AA Farahani… - Modern Pathology: an …, 2020 - europepmc.org
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical
behavior, histologic characteristics, and molecular landscape are not well understood. We …